758
Y.-J. Ko et al. / Journal of Fluorine Chemistry 127 (2006) 755–759
2
2
MOM), 121.44 (t, JC–F = 16.4 Hz, C-4), 134.19 (dd, JC–
F = 23.4 Hz and 4JC–F = 4.6 Hz, C-2 and C-6), 157.05 (dd, 1JC–
F = 262.6 Hz, 3JC–F = 3 Hz, C-3 and C-5); 19F NMR (470 MHz,
CDCl3): d À131.67 (s, 2F, CF); IR (neat) 3020, 2927, 1520,
1423, 1219, 773 cmÀ1; EIMS (70 eV, m/z): 189 [M]+ (14), 159
[M + H–OCH3] (75), 128 [M À OMOM] (100); HRMS (EI):
calcd. for C8H9O2NF2: 189.0601, found: 189.0565.
mixture was cooled to 0 8C and then treated with sat aq NaCO3
solution (10 mL). The product was extracted with dichlor-
omethane (3 Â 30 mL), dried over MgSO4, filtered, and
carefully concentrated under reduced pressure at room
temperature. The crude material was purified by silica gel
column chromatography (eluting with ethyl acetate/hexane,
1:3) to provide 75 mg (97% yield) of the desired product as a
1
white solid: mp 99–101 8C; H NMR (600 MHz, CDCl3): d
4.2.3. 3-Bromo-5-fluoro-4-methoxymethoxymethylpyridine,
7b
Red liquid; 1H NMR (600 MHz, CDCl3): d 3.41 (3H, s, CH3
in MOM), 4.74 (2H, s, CH2–C4), 4.75 (2H, s, CH2 in MOM),
8.42 (1H, s, H-6), 8.59(1H, s, H-2); 13C NMR (150 MHz,
4.84 (2H, s, C4–CH2), 8.35 (2H, s, H-2 and H-6); 13C NMR
(150 MHz, CDCl3): d 52.6 (t, 3JC–F = 3.6 Hz, CH2–C4), 124.2
2
2
3
(t, JC–F = 16.5 Hz, C-4), 134.5 (dd, JC–F = 23.8 Hz and JC–
1
3
F = 4.6 Hz, C-2 and C-6), 157.8 (dd, JC–F = 262 Hz and JC–
F = 3.2 Hz, C-3 and C-5); 19F NMR (470 MHz, CDCl3): d
À132.72 (s, 2F, CF); IR (neat) 3020, 1522, 1425, 1402, 1217,
771 cmÀ1; EIMS (70 eV, m/z): 145 [M]+ (100), 116 [M + H–
CH2OH] (40), 96 [M–CH2OH–F] (20); HRMS (EI): calcd. for
C8H9O2NF2: 145.0339, found: 145.0344.
3
CDCl3): d 55.80 (CH3 in MOM), 61.66 (d, JC–F = 2.6 Hz,
CH2–C4), 96.86 (CH2 in MOM), 123.40 (C-3), 133.31 (d, 2JC–
2
F = 14.8 Hz, C-4), 137.20 (d, JC–F = 25 Hz, C-6), 148.19 (d,
4JC–F = 4.9 Hz, C-2), 158.29 (d, JC–F = 263.6 Hz, C-5); 19F
1
NMR (470 MHz, CDCl3): d À129.56 (s, 1F, CF); IR (neat)
3020, 2927, 1520, 1423, 1219, 773 cmÀ1; EIMS (70 eV, m/z)
250 [M + 2]+ (14), 248 [M]+ (12), 219 [M À 2H–OCH3] (38),
204 [M À H À MOM] (24), 188 [M À H À OMOM] (100);
HRMS (EI): calcd. for C8H9O2NBrF: 248.9801, found:
248.9806.
4.4. Preparation of 3,5-difluoro-pyridine-4-carbaldehyde,
2
4.4.1. Method A: from (3,5-difluoro-pyridin-4-yl)methanol
4.4.1.1. Swern oxidation. To a solution of oxalyl chloride
(0.15 mL, 1.73 mmol) in dichloromethane (10 mL) under N2 at
À60 8C was added dropwise a solution of DMSO (0.25 mL,
3.45 mmol) in dichloromethane (2 mL). The mixture was
stirred for 10 min, and then a solution of (3,5-difluoro-pyridin-
4-yl)methanol (100 mg, 0.69 mmol) in dichloromethane
(2 mL) was added dropwise. The reaction mixture was stirred
for 20 min, and the mixture was warmed to room temperature.
Next, Et3N (0.6 mL, 4.31 mmol) was added flowed by H2O.
The organic layer was separated and the aqueous phase
extracted with dichloromethane (3 Â 30 mL). The combined
organic layer were washed with H2O, 5% aq NaHCO3 solution,
and brine. Removal of the solvent afforded a crude residue,
which was filtered through a plug of silica gel using
dichloromethane and the filtrate was carefully concentrated
under reduced pressure at room temperature. Finally, the
product 2 (very volatile!) was purified through a bulb-to-bulb
distillation. A white solid (83 mg, 84% yield) was obtained.
4.2.4. 4-[1,3]Dioxolan-2-yl-3,5-difluoropyridine, 9a
This product was prepared from 8 as described above:
Yellow solid; mp 121–123 8C; 1H NMR (500 MHz, CDCl3): d
4.05–4.08 (2H, m, H-4 and H-5 in dioxolan), 4.21–4.24 (2H, m,
H-4 and H-5 in dioxolan), 6.26 (1H, s, H-2 in dioxolan), 8.35
(1H, s, H-2 and H-6); 13C NMR (125 MHz, CDCl3): d 66.3 (C-4
and C-5 in dioxolan), 96.3 (t, 3JC–F = 3.5 Hz, C-2 in dioxolan),
2
122.2 (t, JC–F = 11.9 Hz, C-4), 135 (dd, JC–F = 23.8 Hz and
1
4JC–F = 5.3 Hz, C-2 and C-6), 157.4 (dd, JC–F = 265 Hz and
3JC–F = 3 Hz, C-3 and C-5); 19F NMR (470 MHz, CDCl3): d
À136.80 (s, 2F, CF); IR (neat) 3020, 1520, 1450, 1402, 1219,
773 cmÀ1; EIMS (70 eV, m/z): 187 [M]+ (66), 186 [M À H]
(55), 142 [M À H–CH2CH2O] (52); HRMS (EI): calcd. for
C8H7O2NF2: 187.0445, found: 187.0408.
4.2.5. 3-Bromo-4-[1,3]dioxolan-2-yl-5-fluoropyridine, 9b
1
Yellow liquid; H NMR (600 MHz, CDCl3): d 4.07–4.10
(2H, m, H-4 and H-5 in dioxolan), 4.24–4.27 (2H, m, H-4 and
H-5 in dioxolan), 6.27 (1H, s, H-2 in dioxolan), 8.40 (1H, s, H-
6), 8.56 (1H, s, H-2); 13C NMR (150 MHz, CDCl3): d 66.4 (C-4
and C-5 in dioxolan), 101 (C-2 in dioxolan), 121 (C-3), 132.6
(d, 2JC–F = 10 Hz, C-4), 138.2 (d, 2JC–F = 25.6 Hz, C-6), 148.6
(d, JC–F = 5.2 Hz, C-2), 158 (d, JC–F = 267.5 Hz, C-5); 19F
NMR (470 MHz, CDCl3): d À129.22 (s, 1F, CF); IR (neat)
3020, 1558, 1410, 1219, 1101, 773 cmÀ1; EIMS (70 eV, m/z):
249 [M + 2]+ (72), 247 [M]+ (73), 204 [M + 2–CH2CH2O] (52),
202 [M–CH2CH2O] (52); HRMS (EI): calcd. for C8H7O2NBrF:
246.9644, found: 246.9658.
4.4.1.2. Oxidation with PCC. To a stirred suspension of PCC
˚
(450 mg, 2.1 mmol) and molecular sieve 4 A (300 mg) in
dichloromethane (100 mL) was added dropwise a solution of
(3,5-difluoro-pyridin-4-yl)-methanol (100 mg, 0.69 mmol) in
dichloromethane (5 mL). The reaction mixture was vigorously
stirred at room temperature under N2 for 1 h. The resulting dark
brown slurry was filtered through a short column of silica and
eluted with dichloromethane and carefully concentrated under
reduced pressure at room temperature. Finally, the product 2
(very volatile!) was purified through a bulb-to-bulb distillation
to provide 77 mg of a white solid (78% yield).
3
1
4.3. Preparation of (3,5-Difluoro-pyridin-4-yl)methanol
4.4.2. Method B: from compound 8
Compound 8 (1.0 g, 5.3 mmol) was dissolved in 12 N aq
HCl solution (15 mL) and the mixture was refluxed with stirring
Compound 7a (100 mg, 0.53 mmol) was dissolved in 10%
aq HCl solution (10 mL) and stirred for 1 h at 60 8C. The